Skip to main content
NVNO logo

NVNO · enVVeno Medical Corp

Track NVNO — free
$10.39 -0.09 (-0.86%) At close · Aug 20
Market Cap
$7.15M
Shares
682,722

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Craig Glynn Resigned 2025-05-20
Jennifer Bright Appointed 2025-05-20
Craig Glynn Appointed 2021-02-24
Craig Glynn Appointed 2021-02-24
Key facts CIK 1661053 CUSIP 29415J205 13F (30d) 17 filings 17 filers Visit website Investor relations